Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy

BACKGROUND: Immune checkpoint inhibitors (ICIs) prolong overall survival (OS) in patients with advanced lung squamous cell carcinoma (LUSC). However, predictive and prognostic factors related to ICIs in LUSC remain elusive. This study aimed to identify predictors that are related to better clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yanjun, Li, Hui, Huang, Zhiyu, Chen, Kaiyan, Yu, Xiaoqing, Sheng, Jiamin, Zhang, Han-Han, Fan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815375/
https://www.ncbi.nlm.nih.gov/pubmed/33489799
http://dx.doi.org/10.21037/tlcr-20-1130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815375/
https://www.ncbi.nlm.nih.gov/pubmed/33489799
http://dx.doi.org/10.21037/tlcr-20-1130

Ejemplares similares